Download PDF
Viszeralchirurgie 2007; 42(5): 292-299
DOI: 10.1055/s-2007-981332
Originalarbeit

© Georg Thieme Verlag Stuttgart · New York

Chirurgische Therapie kolorektaler Lebermetastasen: Möglichkeiten und Grenzen

Surgical Therapy for Colorectal Liver Metastases: Prospects and LimitsT. Lorf1 , K. Homayounfar1 , T. Liersch1 , M. Niessner1 , G. Schütze2 , B. M. Ghadimi1 , H. Becker1
  • 1Klinik für Allgemein- und Viszeralchirurgie, Universitätsmedizin Göttingen, Georg-August-Universität
  • 2Diagnostische Radiologie, Universitätsmedizin Göttingen, Georg-August-Universität
Further Information

Publication History

Publication Date:
04 October 2007 (online)

    Permissions and Reprints

Zusammenfassung

Lebermetastasen treten bei 40 % der Patienten mit kolorektalen Karzinomen auf. Die Verbesserung der chirurgischen Techniken und des perioperativen Managements haben zu einer deutlichen Senkung der Morbidität und Mortalität der Lebermetastasenresektion (LMR) geführt. Vor dem Hintergrund eines zunehmenden Verständnisses der Tumorbiologie einerseits und deutlich verbesserter Überlebensraten andererseits ist in den letzten Jahren die Indikationsstellung zur LMR in spezialisierten Zentren erweitert worden. Die Therapiestrategie verlagerte sich dabei von einer resektionstechnisch standardisierten Intervention zu einem individualisierten, interdisziplinär geplanten Behandlungskonzept, das sowohl eine präoperative Chemotherapie, mehrzeitige Leberresektionen als auch die ausgedehnte Resektion extrahepatischer Tumormanifestationen umfasst. Ziel dieser Arbeit ist es, den gegenwärtigen Stellenwert der LMR im interdisziplinären Behandlungskonzept darzustellen. Dabei werden insbesondere Grenzsituationen betrachtet, in denen in der Vergangenheit ausschließlich palliative Chemotherapien als einzig sinnvolle onkologische Therapieoption angesehen wurden.

Abstract

40 % of patients suffering from colorectal cancer will develop liver metastases during the course of their disease. Advances in both surgical technique and perioperative management lead to a decrease in postoperative morbidity and mortality. Against the background of an increasing understanding of tumor biology as well as excellent survival data following hepatic resection, the indication for liver resection has been extended in specialized surgical centers. Similarly the intention to treat changed from a standardized resection towards an individual and interdisciplinary therapy including preoperative chemotherapy, staged liver resection and resection of extrahepatic disease. The aim of this study is to investigate the current value of hepatic resection for colorectal liver metastases in the interdisciplinary oncological concept. It specially addresses these challenging situations where palliative chemotherapy seemed to be the only reasonable way of therapy in past.

Schlüsselwörter

kolorektale Lebermetastasen - Pfortaderligatur - wiederholte Leberresektion - extrahepatische Tumormanifestation - Resektionsrand

Key words

colorectal liver metastases - portal vein ligation - recurrent liver resection - extrahepatic disease - resection margin

Literatur

  • 1 Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004.  Annals of Oncology. 2005;  16 481-488
    CrossrefPubMedGoogle Scholar
  • 2 Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D. et al . Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.  Ann Surg. 2004;  240 644-657
    Google Scholar
  • 3 Bengtsson G, Carlsson G, Hafstrom L, Jonsson P E. Natural history of patients with untreated liver metastases from colorectal cancer.  Am J Surg. 1981;  141 586-589
    CrossrefPubMedGoogle Scholar
  • 4 Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W. et al . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.  N Engl J Med. 2004;  50 335-342
    PubMedGoogle Scholar
  • 5 Abdallah E K, Vauthey J N, Ellis L M, Ellis V, Pollock R, Broglio K R. et al . Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection / ablation for colorectal liver metastases.  Ann Surg. 2004;  239 818-827
    CrossrefPubMedGoogle Scholar
  • 6 Pawlik T M, Scoggins C R, Zorzi D, Abdallah E K, Andres A, Eng C. et al . Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.  Ann Surg. 2005;  241 715-724
    CrossrefPubMedGoogle Scholar
  • 7 Foster J H. Survival after liver resection for secondary tumors.  Am J Surg. 1978;  135 389-394
    CrossrefPubMedGoogle Scholar
  • 8 Stone H H, Long W D, Smith R B, Haynes C D. Physiologic considerations in major hepatic resections.  Am J Surg. 1969;  117 78-84
    CrossrefPubMedGoogle Scholar
  • 9 Fong Y, Fortner J, Sun R L, Brennan M F, Blumgart L H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer.  Ann Surg. 1999;  230 309-321
    CrossrefPubMedGoogle Scholar
  • 10 Jarnagin W R, Gonen M, Fong Y, DemAtteo R P, Ben-Porat L, Little S. et al . Improvement in perioperative outcome after hepatic resection.  Ann Surg. 2002;  236 397-407
    CrossrefPubMedGoogle Scholar
  • 11 Hayashi S, Masuda H, Shigematsu M. Liver metastasis rare in colorectal cancer patients with fatty liver.  Hepatogastroenterology. 1997;  44 1069-1075
    PubMedGoogle Scholar
  • 12 Utsunomiya T, Saitu H, Saku M, Yoshida K, Matsumata T, Shimada M. et al . Rare occurrence of colorectal cancer metastasis in livers infected with hepatitis B or C virus.  Am J Surg. 1999;  177 279-281
    CrossrefPubMedGoogle Scholar
  • 13 Nagasue N, Ono T, Yamanoi A, Kohno H, El-Assal O N, Taniura H. et al . Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.  Br J Surg. 2001;  88 515-522
    CrossrefPubMedGoogle Scholar
  • 14 Zhou L, Rui J A, Wang S B, Chen S G, Qu Q, Chi T Y. et al . Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy.  World J Surg. 2007;  31 1782-1787
    CrossrefPubMedGoogle Scholar
  • 15 Bartolozzi C, Donati F, Cioni D, Procacci C, Morana G, Chiesa A. et al . Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.  Eur Radiol. 2004;  14 14-20
    CrossrefPubMedGoogle Scholar
  • 16 Scaife C L, Ng C S, Ellis L M, Vauthey J N, Charnsangavej C, Curley S A. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI.  Ann Surg Oncol. 2006;  13 542-546
    CrossrefPubMedGoogle Scholar
  • 17 Bipat S, van Leeuwen M S, Comans E F, Pijl M E, Bossuyt P M, Zwinderman A H. et al . Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis.  Radiology. 2005;  237 123-131
    CrossrefPubMedGoogle Scholar
  • 18 Ruers T J, Langenhoff B S, Neeleman N, Jager G J, Strijk S, Wobbes T. et al . Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.  J Clin Oncol. 2002;  20 388-395
    CrossrefPubMedGoogle Scholar
  • 19 Fernandez F G, Drebin J A, Linehan D C, Dehdashti F, Siegel B A, Strasberg S M. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).  Ann Surg. 2004;  240 438-447
    CrossrefPubMedGoogle Scholar
  • 20 Van Cutsem E, Nordlinger B, Adam R, Koehne C H, Pozzo C, Poston G. et al. on behalf of European Colorectal Metastases Treatment Group . Towards a pan-European consensus on the treatment of patients with colorectal liver metastases.  Eur J Cancer. 2006;  42 2212-2221
    CrossrefPubMedGoogle Scholar
  • 21 Nordlinger B, Guiguet M, Vaillant J C, Balladur P, Boudjema K, Bachellier P. et al . Surgical Resection of Colorectal Carcinoma Metastases to the Liver.  Cancer. 1996;  77 1254-1262
    CrossrefPubMedGoogle Scholar
  • 22 Gog C, Bechstein W O. Interdisziplinäres Management resektabler kolorektaler Lebermetastasen.  Viszeralchirurgie. 2007;  42 94-101
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Van de Velde C JH. Treatment of liver metastases of colorectal cancer.  Ann Oncol. 2005;  16 (S 2) ii144-ii149
    CrossrefPubMedGoogle Scholar
  • 24 Niiya T, Murakami M, Aoki T, Murai N, Shimizu Y, Kusano M. Immediate increase of portal pressure, reflecting sinusoidal shear stress, induced liver regeneration after partial hepatectomy.  J Hepatobiliary Pancreat Surg. 1999;  6 275-280
    CrossrefPubMedGoogle Scholar
  • 25 Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R. et al . Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases.  J Am Coll Surg. 2003;  197 233-241
    CrossrefPubMedGoogle Scholar
  • 26 Capussotti L, Ferrero A, Viganó L, Ribero D, Lo Tesoriere R. et al . Major liver resections synchronous with colorectal surgery.  Ann Surg Oncol. 2007;  14 195-201
    CrossrefPubMedGoogle Scholar
  • 27 Yan T D, Chu F, Black D, King D W, Morris D L. Synchronous resection of colorectal primary cancer and liver metastases.  World J Surg. 2007;  31 1496-1501
    CrossrefPubMedGoogle Scholar
  • 28 Gruttadauria S, Vasta F, Minervini M I, Piazza T, Arcadipane A, Marcos A. et al . Significance of effective remnant liver volume in major hepatectomies.  Am Surg. 2005;  71 235-240
    PubMedGoogle Scholar
  • 29 Van Thiel D H, Hagler N G, Schade R R, Skolnick M L, Pollitt Heyl A, Rosenblum E. et al . In vivo hepatic volume determination using sonography and computed tomography.  Gastroenterology. 1985;  88 1812-1817
    PubMedGoogle Scholar
  • 30 Truant S, Oberlin O, Sergent G, Lebuffe G, Gambiez L, Ernst O. et al . Remnant Liver Volume to Body Weight Ratio > 0.5 %: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver.  J Am Coll Surg. 2007;  204 22-33
    CrossrefPubMedGoogle Scholar
  • 31 Covey A M, Brody L A, Getrajdman G I, Sofocleus C T, Brown K T. Incidence, patterns, and clinical relevance of variant portal vein anatomy.  Am J Roentgenol. 2004;  183 1055-1064
    PubMedGoogle Scholar
  • 32 Rous P, Larimore L D. Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation.  J Exp Med. 1920;  36 585
    PubMedGoogle Scholar
  • 33 Broering D C, Hillert C, Krupski G, Fischer L, Mueller L, Achilles E G. et al . Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.  J Gastrointest Surg. 2002;  6 905-913
    CrossrefPubMedGoogle Scholar
  • 34 Krupski G, Broering D C, Wittkugel O, Mueller L, Nicolas V, Rogiers X. et al . Portale Kollateralenbildung nach Pfortaderligatur zur Leberregenerations-Induktion im Schweine-Modell.  Fortschr Röntgenstr. 2002;  174 1281-1284
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Elias D, de Baere T, Roche A, Ducreux M, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than of the liver parenchyma.  Br J Surg. 1999;  86 784-788
    Google Scholar
  • 36 Elias D, Santoro R, Oulellet J F, Osmak L, de Baere T, Roche A. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major hepatic resection for bilateral colorectal metastases.  Hepatogastroenterology. 2004;  51 1788-1791
    Google Scholar
  • 37 Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber J C, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobular colorectal liver metastases.  Ann Surg. 2004;  240 1037-1051
    CrossrefPubMedGoogle Scholar
  • 38 Hughes K S, Simon R, Songhorabodi S, Adson M A, Ilstrup D M, Fortner J G. et al . Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.  Surgery. 1986;  100 278-284
    PubMedGoogle Scholar
  • 39 Tanaka K, Shimada H, Ohta M, Togo S, Saitou S, Yamaguchi S. et al . Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer.  World J Surg. 2004;  28 482-487
    CrossrefPubMedGoogle Scholar
  • 40 Pessaux P, Lermite E, Brehant O, Tuech J J, Lorimier G, Arnaud J P. Repeat hepatectomy for recurrent colorectal liver metastases.  J Surg Oncol. 2006;  93 1-7
    CrossrefPubMedGoogle Scholar
  • 41 Shaw I M, Rees M, Welsh F KS, Bygrave S, John T G. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival.  Br J Surg. 2006;  93 457-464
    CrossrefPubMedGoogle Scholar
  • 42 Thelen A, Jonas S, Benckert C, Schumacher G, Lopez-Hänninen E, Rudolph B. et al . Repeat liver resection for recurrent liver metastases from colorectal cancer.  Eur J Surg Oncol. 2007;  33 324-328
    CrossrefPubMedGoogle Scholar
  • 43 Antoniou A, Lovegrove R E, Tilney H S, Heriot A G, John T G, Rees M. et al . Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases.  Surgery. 2007;  141 9-18
    CrossrefPubMedGoogle Scholar
  • 44 Garden O J, Rees M, Poston G J, Mirza D, Saunders M, Ledermann J. et al . Guidelines for resection of colorectal cancer liver metastases.  Gut. 2006;  55 (S 3) iii1-iii8
    CrossrefPubMedGoogle Scholar
  • 45 Elias D, Ouellet J F, Bellon N, Pignon J P, Pocard M, Lasser P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases.  Br J Surg. 2003;  90 567-574
    CrossrefPubMedGoogle Scholar
  • 46 Shah S A, Haddad R, Al-Sukhni W, Kim R D, Greig P D, Grant D R. et al . Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.  J Am Coll Surg. 2006;  202 468-475
    CrossrefPubMedGoogle Scholar
  • 47 Miller G, Biernacki P, Kemeny N E, Gonen M, Downey R, Jarnagin W R. et al . Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.  J Am Coll Surg. 2007;  205 231-238
    CrossrefPubMedGoogle Scholar
  • 48 Elias D, Benizri E, Pocard M, Ducreux M, Boige V, Lasser P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer.  Eur J Surg Oncol. 2006;  32 632-636
    CrossrefPubMedGoogle Scholar
  • 49 Carmignani C P, Ortega-Perez G, Sugarbaker P H. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer.  Eur J surg Oncol. 2004;  30 391-398
    CrossrefPubMedGoogle Scholar
  • 50 Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan T D, Alexander R. et al . Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement.  Ann Surg Oncol. 2007;  14 128-133
    PubMedGoogle Scholar
  • 51 Hohenberger P, Schlag P, Herfarth C. Erweiterte Resektion von Lebermetastasen beim kolorektalen Karzinom.  Langenbecks Arch Chir. 1993;  378 110-114
    PubMedGoogle Scholar
  • 52 Miyazaki M, Ito H, Nakawaga K, Ambiru S, Shimizu H, Okuno A. et al . Aggressive surgical resection for hepatic metastases involving the inferior vena cava.  Am J Surg. 1999;  177 294-298
    CrossrefPubMedGoogle Scholar
  • 53 Johnson S T, Blitz M, Kneteman N, Bigam D. Combined hepatic and inferior vena cava resection for colorectal metastases.  J Gastointest Surg. 2006;  10 220-226
    PubMedGoogle Scholar
  • 54 Hemming A W, Reed A I, Langham M R, Fujita S, Howard R J. Combined resection of the liver and inferior vena cava for hepatic malignancy.  Ann Surg. 2004;  239 712-721
    CrossrefPubMedGoogle Scholar
  • 55 Rubbia-Brandt L, Audard V, Sartiretti P, Roth A D, Brezault C, Le Charpentier M. et al . Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.  Ann Oncol. 2004;  15 460-466
    Google Scholar
  • 56 Bilchik A J, Poston G, Curley S A, Strasberg S, Saltz L, Adam. et al . Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note.  J Clin Oncol. 2005;  23 9073-9078
    CrossrefPubMedGoogle Scholar
  • 57 Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B. et al . Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.  Ann Surg. 2006;  243 1-7
    Google Scholar
  • 58 Vauthey J N, Pawlik T M, Ribero D, Wu T T, Zorzi D, Hoff P M. et al . Chemotherapy regimen predicts steatohepatitis and an increase in 90-day-mortality after surgery for hepatic colorectal metastases.  J Clin Oncol. 2006;  24 2065-2072
    Google Scholar
  • 59 Hughes K S, Simon R, Songhorabodi S, Adson M A, Ilstrup D M, Fortner J G. et al . Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection.  Surgery. 1988;  103 278-288
    Google Scholar
  • 60 Hamady Z Z, Cameron I C, Wyatt J, Prasad R K, Toogood G J, Lodge J P. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule.  Eur J Surg Oncol. 2006;  32 557-563
    CrossrefPubMedGoogle Scholar
  • 61 Gayowski T J, Iwatsuki S, Madariaga J R, Selby R, Todo S, Irish W. et al . Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.  Surgery. 1994;  116 703-711
    PubMedGoogle Scholar
  • 62 Poston G, Haller D, Kahan J, Cornelis M, Mahyaoui S. OncoSurge International Taskforce Group . Individualizse the treatment of liver metastases from colorectal cancer using RAND appropriateness method: Oncosurge decision model. Results of a consensus detecting from the international taskforce group.  J Clin Oncol. 2004;  22 3595 ,  (S 14 ASCO Annual Meeting Proceedings)
    PubMedGoogle Scholar
  • 63 Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D. et al . The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy.  Ann Surg. 2005;  242 824-829
    CrossrefPubMedGoogle Scholar

Dr. med. T. Lorf

Klinik für Allgemein- und Viszeralchirurgie · Universitätsmedizin Göttingen · Georg-August-Universität

Robert-Koch-Straße 40

37099 Göttingen

Phone: 05 51 / 39 24 12

Email: tlorf@med.uni-goettingen.de

      >